A number of clinical prospective studies have shown that the Apo B/ApoA1 ratio is the risk factor for cardiovascular, osteoarthritis, rheumatoid arthritis, and metabolic syndrome disease [19–21, 27, 34–36]. This evidence concerns the gene APOB and rheumatoid arthritis.